BriaCell Therapeutics Corp.
BriaCell Therapeutics Corp.
BriaCell Therapeutics Corp. (BCTX) — SEC Financial Statements & Analysis
BriaCell Therapeutics Corp. (BCTX) files its annual 10-K and quarterly 10-Q reports directly with the SEC. The financial data below is sourced as-filed from EDGAR — balance sheet, income statement, and cash flow as reported, without normalization or third-party adjustments.
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Financial Statements
Values in Millions ($) | 2026-04-30 | 2026-01-31 | 2025-10-31 | 2025-07-31 | 2025-04-30 | 2025-01-31 | 2024-10-31 | 2024-07-31 | 2024-04-30 | 2024-01-31 | 2023-10-31 | 2023-07-31 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets | |||||||||||||||||
Assets Current | |||||||||||||||||
Cash And Cash Equivalents At Carrying Value | 7 | 30 | 3 | 10 | 12 | 5 | 6 | 1 | 1 | 6 | 14 | 21 | |||||
Accounts Receivable Net Current | - | - | - | - | - | - | - | - | 0 | 0 | 0 | 0 | |||||
Prepaid Expense Current | - | - | - | - | - | - | - | - | 5 | 5 | 5 | 6 | |||||
Short Term Investments | 16 | - | 7 | 7 | - | - | - | - | - | - | - | - | |||||
Assets Current | 25 | 32 | 11 | 20 | 15 | 7 | 8 | 4 | 6 | 12 | 18 | 27 | |||||
Equity Method Investments | - | - | - | - | - | - | - | - | 0 | 0 | 0 | 0 | |||||
Assets Noncurrent | |||||||||||||||||
Equity Securities F V N I Noncurrent | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | |||||
Finite Lived Intangible Assets Net | - | - | - | - | - | - | - | - | 0 | 0 | 0 | 0 | |||||
Intangible Assets Net Excluding Goodwill | - | - | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - | 0 | |||||
Intangible Assets Net Including Goodwill | 0 | - | - | - | - | - | - | - | - | - | - | - | |||||
Property Plant And Equipment Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - | - | |||||
Prepaid Expense Noncurrent | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | - | - | - | - | |||||
Assets Noncurrent | 2 | 1 | 2 | 2 | 2 | 2 | 2 | 2 | 1 | 0 | 0 | 0 | |||||
Assets | 27 | 34 | 13 | 22 | 17 | 9 | 10 | 6 | 6 | 12 | 19 | 27 | |||||
Liabilities And Stockhold… | |||||||||||||||||
Liabilities Current | |||||||||||||||||
Accounts Payable Trade Current | 2 | 2 | 2 | 3 | 3 | 5 | 4 | 7 | 6 | 4 | 0 | 1 | |||||
Accounts Payable And Other Accrued Liabilities Cur… | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 1 | |||||
Liabilities Current | 4 | 3 | 3 | 4 | 4 | 5 | 5 | 7 | 7 | 4 | 1 | 2 | |||||
Liabilities Noncurrent | |||||||||||||||||
Derivative Liabilities Noncurrent | 0 | 0 | 0 | 0 | 1 | 1 | 2 | 1 | 6 | - | - | 29 | |||||
Liabilities Noncurrent | 0 | 0 | 0 | 0 | 1 | 1 | 2 | 1 | 6 | 17 | 15 | 29 | |||||
Stockholders Equity | |||||||||||||||||
Common Stock Value | 117 | 117 | 102 | 102 | 94 | 85 | 82 | 72 | 70 | 70 | 70 | 70 | |||||
Additional Paid In Capital | - | - | - | - | - | - | - | - | - | - | 8 | - | |||||
Accumulated Other Comprehensive Income Loss Net Of… | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | |||||
Minority Interest | -1 | -1 | -1 | -1 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | - | |||||
Retained Earnings Accumulated Deficit | -134 | -127 | -120 | -112 | -104 | -98 | -91 | -85 | -84 | -86 | -75 | -81 | |||||
Stockholders Equity | 23 | 30 | 9 | 17 | 12 | 3 | 4 | -3 | -6 | -8 | 3 | -4 | |||||
Liabilities And Stockholders Equity | 27 | 34 | 13 | 22 | 17 | 9 | 10 | 6 | 6 | 12 | 19 | 27 | |||||
Common Stock Par Or Stated Value Per Share | - | - | - | - | - | - | - | - | - | 0 | - | 0 | |||||
Common Stock No Par Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | 0 | 0 | |||||
Common Stock Shares Issued | 36 | 36 | - | 38 | 39 | - | 36 | 0 | 2 | 2 | 2 | 2 | |||||
Shares Outstanding | 7 | 7 | - | 8 | 7 | 0 | 36 | 0 | 2 | 2 | 2 | 2 | |||||
Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables
Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables
Custom Table
Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals
Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals
Interactive Financial Visualizations
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Earnings Market Reaction
| Fiscal Year | Q1 1 Month | Q1 2 Month | Q1 3 Month | Q2 1 Month | Q2 2 Month | Q2 3 Month | Q3 1 Month | Q3 2 Month | Q3 3 Month | Q4 1 Month | Q4 2 Month | Q4 3 Month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -30.46% | -58.29% | -62.95% | 7.61% | 9.71% | -4.46% | 6.19% | - | - | - | - | - |
| 2025 | -34.43% | 511.48% | 478.69% | 7.95% | 9.59% | -5.75% | -36.08% | -77.53% | -75.09% | -8.20% | -7.55% | -41.80% |
| 2024 | 28.33% | -7.38% | -17.38% | -14.14% | -22.41% | -52.07% | -28.87% | -50.70% | -44.37% | -12.05% | -32.53% | -54.22% |
| 2023 | - | - | - | - | - | - | 8.60% | 12.31% | 16.36% | -10.49% | -15.02% | -9.67% |
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial | ||||||||||||
Subscribe to unlock 17+ years of financial data and 50+ calculated metrics
Subscribe to unlock 17+ years of data and 50+ calculated metrics
Performance and Valuation Metrics
Metrics | 2026-04-30 | 2026-01-31 | 2025-10-31 | 2025-07-31 | 2025-04-30 | 2025-01-31 | 2024-10-31 | 2024-07-31 | 2024-04-30 | 2024-01-31 | 2023-10-31 | 2023-07-31 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Liquidity Ratios | |||||||||||||||||
| Current Ratio | 7.07 | 10.10 | 3.42 | 5.01 | 3.41 | 1.37 | 1.65 | 0.49 | 0.82 | 2.99 | 17.59 | 14.96 | |||||
| Quick Ratio | 7.07 | 10.10 | 3.42 | 5.01 | 3.41 | 1.37 | 1.65 | 0.49 | 0.14 | 1.60 | 13.06 | 11.81 | |||||
| Working Capital | 21.80M | 28.99M | 8.03M | 15.95M | 10.45M | 1.93M | 3.23M | -3.81M | -1.23M | 7.82M | 17.36M | 25.15M | |||||
Leverage & Debt | |||||||||||||||||
| Debt to Equity | 0.16 | 0.11 | 0.40 | 0.25 | 0.42 | 1.90 | 1.80 | -3.19 | -2.00 | -2.47 | 6.40 | -8.19 | |||||
| Debt Ratio | 0.14 | 0.10 | 0.28 | 0.20 | 0.30 | 0.66 | 0.64 | 1.46 | 2.00 | 1.68 | 0.86 | 1.14 | |||||
Efficiency & Turnover | |||||||||||||||||
| Asset Turnover TTM | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||
| Receivables Turnover TTM | - | - | - | - | - | - | - | - | 0.00 | 0.00 | 0.00 | 0.00 | |||||
Per Share Metrics | |||||||||||||||||
| Diluted EPS TTM | -4.29 | -3.57 | -5.14 | -5.23 | -4.34 | -3.58 | -7.79 | -1.82 | -2.34 | -4.93 | -4.95 | -8.12 | |||||
| Free Cash Flow Per Share TTM | -6.43 | -5.22 | -7.40 | -8.08 | -8.25 | -6.79 | -11.01 | -9.16 | -12.13 | -12.22 | -10.87 | -9.50 | |||||
| Dividend Per Share TTM | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||
Growth Metrics | |||||||||||||||||
| Net Income Growth (1Y) | 59.90% | 159.12% | 74.94% | 454.24% | 224.13% | -8.05% | 25.78% | -76.40% | -66.47% | - | - | - | |||||
| EPS Growth (1Y) | -1.27% | -0.15% | -34.03% | 187.39% | 85.14% | -27.42% | 50.90% | -77.60% | -67.45% | - | - | - | |||||
Valuation Metrics | |||||||||||||||||
| P/E TTM | -0.98 | -1.20 | -2.14 | -1.43 | -10.27 | -14.03 | -1.04 | -4.12 | -9.25 | -8.36 | -8.24 | -8.24 | |||||
| P/B | 1.29 | 1.20 | 6.65 | 2.20 | 16.72 | 50.40 | 4.65 | -7.35 | -8.90 | -12.67 | 43.19 | -44.26 | |||||
| Market Cap | 30.31M | 36.15M | 62.17M | 38.08M | 199.67M | 162.62M | 17.26M | 19.75M | 55.49M | 105.35M | 108.68M | 167.19M | |||||
| Enterprise Value | 23.43M | 6.25M | 59.45M | 27.59M | 187.21M | 157.61M | 11.47M | 18.88M | 54.55M | 99.11M | 95.03M | 145.94M | |||||
Calculated Values | |||||||||||||||||
| Free Cash Flow TTM | -46.62M | -43.84M | -41.80M | -41.05M | -36.95M | -21.99M | -23.48M | -24.13M | -31.01M | -31.26M | -27.81M | -23.74M | |||||
| Net Debt | -6.88M | -29.90M | -2.71M | -10.49M | -12.46M | -5.01M | -5.79M | -862.09K | -935.69K | -6.24M | -13.65M | -21.25M | |||||
Per-Share and Margin | |||||||||||||||||
| EPS TTM | |||||||||||||||||
| Adjusted EPS TTM | |||||||||||||||||
| Cash Flow Per Share TTM | |||||||||||||||||
| Pretax Margin TTM | |||||||||||||||||
| Stock Comp to Revenue TTM | |||||||||||||||||
Turnover Ratios and Averages | |||||||||||||||||
| Average Assets | |||||||||||||||||
| Average Equity | |||||||||||||||||
| Average Inventory | |||||||||||||||||
| Average Receivables | |||||||||||||||||
| Average Accounts Payables | |||||||||||||||||
| Inventory Turnover TTM | |||||||||||||||||
| Payables Turnover TTM | |||||||||||||||||
| Days Inventory Outstanding TTM | |||||||||||||||||
| Days Payables Outstanding TTM | |||||||||||||||||
| Cash Conversion Cycle TTM | |||||||||||||||||
| Working Capital to Revenue | |||||||||||||||||
| Deferred Revenue to Revenue | |||||||||||||||||
Growth Rates | |||||||||||||||||
| Total Assets Growth (1Y) | |||||||||||||||||
| Total Assets Growth (3Y) | |||||||||||||||||
| Total Assets Growth (5Y) | |||||||||||||||||
| Dividends Paid Growth (1Y) | |||||||||||||||||
| Dividends Paid Growth (3Y) | |||||||||||||||||
| Dividends Paid Growth (5Y) | |||||||||||||||||
| EPS Growth (3Y) | |||||||||||||||||
| EPS Growth (5Y) | |||||||||||||||||
| Net Income Growth (3Y) | |||||||||||||||||
| Net Income Growth (5Y) | |||||||||||||||||
| Net Profit Margin Growth (1Y) | |||||||||||||||||
| Net Profit Margin Growth (3Y) | |||||||||||||||||
| Net Profit Margin Growth (5Y) | |||||||||||||||||
| Net Revenue Growth (3Y) | |||||||||||||||||
| Net Revenue Growth (5Y) | |||||||||||||||||
| Deferred Revenue Growth (1Y) | |||||||||||||||||
| Retained Earnings Growth (1Y) | |||||||||||||||||
Credit, Liquidity, Returns, Payout | |||||||||||||||||
| Cash Ratio | |||||||||||||||||
| Net Working Capital | |||||||||||||||||
| Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to Equity | |||||||||||||||||
| Altman A | |||||||||||||||||
| Altman B | |||||||||||||||||
| Altman C | |||||||||||||||||
| Altman D | |||||||||||||||||
| Altman E | |||||||||||||||||
| Altman Z-Score | |||||||||||||||||
| ROA TTM | |||||||||||||||||
| ROE TTM | |||||||||||||||||
| NOPAT TTM | |||||||||||||||||
| ROIC TTM | |||||||||||||||||
| Effective Tax Rate TTM | |||||||||||||||||
| Payout Ratio TTM | |||||||||||||||||
| Dilution Ratio | |||||||||||||||||
| Retained Earnings to Equity | |||||||||||||||||
| Treasury Stock to Equity | |||||||||||||||||
| Treasury Stock Change (1Y) | |||||||||||||||||
| Accrued to Current Liabilities | |||||||||||||||||
Valuation Ratios | |||||||||||||||||
| P/CF TTM | |||||||||||||||||
| Dividend Yield TTM | |||||||||||||||||
| Free Cash Flow Yield TTM | |||||||||||||||||
| EV EBITDA TTM | |||||||||||||||||
| EV EBIT TTM | |||||||||||||||||
| Stock Compensation TTM | |||||||||||||||||
| Adjusted Net Income TTM | |||||||||||||||||
| Billings TTM | |||||||||||||||||
| Total Debt | |||||||||||||||||
| Invested Capital | |||||||||||||||||
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Insider Transactions
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data